MICROLEARNING Strategy Matters: How to Increase RSV Vaccination Rates in Older Patients

Statement of Need
Respiratory syncytial virus (RSV) is increasingly recognized as a key source of respiratory illness in older adults. In a 2022 Call to Action, the National Foundation for Infectious Diseases (NFID) noted approximately 177,000 RSV-related hospitalizations each year in older adults, adding that patients ages 65 and older carry a much larger RSV-associated mortality burden than do children. Continuing education that brings clinicians on the front lines of preventative primary care up to speed on RSV immunization recommendations for adults and strategies for increasing vaccination rates in this population can contribute to an improved rate of coverage—and ultimately fewer adverse respiratory outcomes. 

Target Audience 
This initiative is designed to address the professional needs of NPs and PAs involved in the care of adult patients.

After participating in this education, learners will be able to: 

• Summarize key aspects of current ACIP recommendations for RSV vaccinations in older adult

           patients, including patients at increased risk for severe RSV 

• Review the most recent efficacy and safety data on FDA-approved RSV vaccines
• Identify underlying causes of vaccine fatigue and vaccine hesitancy

CREDIT DESIGNATIONS 

Albert Einstein College of Medicine-Montefiore Medical Center designates this live activity for a maximum of 0.25 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Albert Einstein College of Medicine-Montefiore Medical Center designates this activity for 0.25 nursing contact hours.  Nurses should claim only credit commensurate with the extent of their participation in the activity 

 This educational activity is supported by an independent medical education grant from GSK.

Content Reviewer  

Una Hopkins, DNP  

Planners  

Núria Waddington Negrão, PhD  

Sapana Panday, MPH 

Financial Disclosures 

The "Policy on Identification, Mitigation, and Disclosure of Relevant Financial Relationships" at Albert Einstein College of Medicine-Montefiore Medical Center mandates that all individuals, including faculty, who have control over content in CME/CE activities, must disclose any relevant financial relationships with ineligible companies*, or the absence of such relationships, from the past 24 months to the audience. Any individual in control of content who refuses to disclose, or their disclosed relationships prove to create a conflict of interest will be recused. 

All financial relationships of individual(s) in a position to control the content of this CME/CE activity has been identified and mitigated prior to this educational activity.  

*The ACCME defines an ineligible company as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.  

Mary Koslap-Petraco DNP, PPCNP-BC, CPNP, FAANP does not have any financial relationships or relationships to products or devices with ineligible companies 

Núria Waddington Negrão, PhD does not have any financial relationships or relationships to products or devices with ineligible companies 

Sapana Panday, MPH does not have any financial relationships or relationships to products or devices with ineligible companies 

Una Hopkins, DNP does not have any financial relationships or relationships to products or devices with ineligible companies